Trademark: 79137943
Word

Status
Dead
Status Code
404
Status Date
Monday, July 24, 2023
Serial Number
79137943
Registration Number
4513199
Registration Date
Tuesday, April 15, 2014
Mark Type
2000
Filing Date
Thursday, July 25, 2013
Published for Opposition
Tuesday, January 28, 2014
Cancellation Date
Tuesday, July 25, 2023

Trademark Owner History
MyMedsandMe Limited - Original Registrant

Classifications
9 Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for capturing information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals
38 Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies
42 Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and/or pharmaceuticals used, reactions and events resulting form the use of medication and/or pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and/or pharmaceuticals; design of computer software for commercial analysis and reporting
The mark consists of a circle above a vertical pill design to resemble a lowercase "I".
Color is not claimed as a feature of the mark.

Trademark Events
Feb 17, 2024
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Feb 17, 2024
Death Of International Registration
Apr 17, 2022
Total Invalidation Processed By The Ib
Mar 11, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Mar 10, 2022
Invalidation Processed
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
Apr 15, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 1, 2014
Final Decision Transaction Processed By Ib
Jul 16, 2014
Final Disposition Notice Sent To Ib
Jul 16, 2014
Final Disposition Processed
Jul 15, 2014
Final Disposition Notice Created, To Be Sent To Ib
Apr 15, 2014
Registered-Principal Register
Jan 28, 2014
Official Gazette Publication Confirmation E-Mailed
Jan 28, 2014
Published For Opposition
Jan 25, 2014
Notification Processed By Ib
Jan 8, 2014
Notification Of Possible Opposition Sent To Ib
Jan 8, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 8, 2014
Notification Of Notice Of Publication E-Mailed
Dec 26, 2013
Law Office Publication Review Completed
Dec 26, 2013
Assigned To Lie
Dec 3, 2013
Refusal Processed By Ib
Dec 3, 2013
Approved For Pub - Principal Register
Nov 18, 2013
Teas Change Of Correspondence Received
Nov 18, 2013
Teas/Email Correspondence Entered
Nov 18, 2013
Correspondence Received In Law Office
Nov 18, 2013
Teas Response To Office Action Received
Nov 13, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Nov 12, 2013
Refusal Processed By Mpu
Nov 12, 2013
Application Filing Receipt Mailed
Nov 9, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Nov 8, 2013
Non-Final Action Written
Nov 7, 2013
Assigned To Examiner
Nov 7, 2013
New Application Office Supplied Data Entered
Nov 4, 2013
Limitation From Original Application Entered
Nov 1, 2013
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24